Global Human Plasma-Derived Therapeutics Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Human Plasma-Derived Therapeutics

• 1.1 Definition of Human Plasma-Derived Therapeutics
• 1.2 Human Plasma-Derived Therapeutics Segment by Type
  • 1.2.1 Global Human Plasma-Derived Therapeutics Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Albumin
  • 1.2.3 Immunoglobulin
  • 1.2.4 Clotting Factor
  • 1.2.5 Prothrombin Complex
  • 1.2.6 Others
• 1.3 Human Plasma-Derived Therapeutics Segment by Applications
  • 1.3.1 Global Human Plasma-Derived Therapeutics Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Research Center
• 1.4 Global Human Plasma-Derived Therapeutics Overall Market
  • 1.4.1 Global Human Plasma-Derived Therapeutics Revenue (2014-2025)
  • 1.4.2 Global Human Plasma-Derived Therapeutics Production (2014-2025)
  • 1.4.3 North America Human Plasma-Derived Therapeutics Status and Prospect (2014-2025)
  • 1.4.4 Europe Human Plasma-Derived Therapeutics Status and Prospect (2014-2025)
  • 1.4.5 China Human Plasma-Derived Therapeutics Status and Prospect (2014-2025)
  • 1.4.6 Japan Human Plasma-Derived Therapeutics Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Human Plasma-Derived Therapeutics Status and Prospect (2014-2025)
  • 1.4.8 India Human Plasma-Derived Therapeutics Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Human Plasma-Derived Therapeutics
• 2.3 Manufacturing Process Analysis of Human Plasma-Derived Therapeutics
• 2.4 Industry Chain Structure of Human Plasma-Derived Therapeutics

3 Development and Manufacturing Plants Analysis of Human Plasma-Derived Therapeutics

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Human Plasma-Derived Therapeutics Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Human Plasma-Derived Therapeutics
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Human Plasma-Derived Therapeutics Production and Capacity Analysis
• 4.2 Human Plasma-Derived Therapeutics Revenue Analysis
• 4.3 Human Plasma-Derived Therapeutics Price Analysis
• 4.4 Market Concentration Degree

5 Human Plasma-Derived Therapeutics Regional Market Analysis

• 5.1 Human Plasma-Derived Therapeutics Production by Regions
  • 5.1.1 Global Human Plasma-Derived Therapeutics Production by Regions
  • 5.1.2 Global Human Plasma-Derived Therapeutics Revenue by Regions
• 5.2 Human Plasma-Derived Therapeutics Consumption by Regions
• 5.3 North America Human Plasma-Derived Therapeutics Market Analysis
  • 5.3.1 North America Human Plasma-Derived Therapeutics Production
  • 5.3.2 North America Human Plasma-Derived Therapeutics Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Human Plasma-Derived Therapeutics Import and Export
• 5.4 Europe Human Plasma-Derived Therapeutics Market Analysis
  • 5.4.1 Europe Human Plasma-Derived Therapeutics Production
  • 5.4.2 Europe Human Plasma-Derived Therapeutics Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Human Plasma-Derived Therapeutics Import and Export
• 5.5 China Human Plasma-Derived Therapeutics Market Analysis
  • 5.5.1 China Human Plasma-Derived Therapeutics Production
  • 5.5.2 China Human Plasma-Derived Therapeutics Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Human Plasma-Derived Therapeutics Import and Export
• 5.6 Japan Human Plasma-Derived Therapeutics Market Analysis
  • 5.6.1 Japan Human Plasma-Derived Therapeutics Production
  • 5.6.2 Japan Human Plasma-Derived Therapeutics Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Human Plasma-Derived Therapeutics Import and Export
• 5.7 Southeast Asia Human Plasma-Derived Therapeutics Market Analysis
  • 5.7.1 Southeast Asia Human Plasma-Derived Therapeutics Production
  • 5.7.2 Southeast Asia Human Plasma-Derived Therapeutics Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Human Plasma-Derived Therapeutics Import and Export
• 5.8 India Human Plasma-Derived Therapeutics Market Analysis
  • 5.8.1 India Human Plasma-Derived Therapeutics Production
  • 5.8.2 India Human Plasma-Derived Therapeutics Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Human Plasma-Derived Therapeutics Import and Export

6 Human Plasma-Derived Therapeutics Segment Market Analysis (by Type)

• 6.1 Global Human Plasma-Derived Therapeutics Production by Type
• 6.2 Global Human Plasma-Derived Therapeutics Revenue by Type
• 6.3 Human Plasma-Derived Therapeutics Price by Type

7 Human Plasma-Derived Therapeutics Segment Market Analysis (by Application)

• 7.1 Global Human Plasma-Derived Therapeutics Consumption by Application
• 7.2 Global Human Plasma-Derived Therapeutics Consumption Market Share by Application (2014-2019)

8 Human Plasma-Derived Therapeutics Major Manufacturers Analysis

• 8.1 Alkahest
  • 8.1.1 Alkahest Human Plasma-Derived Therapeutics Production Sites and Area Served
  • 8.1.2 Alkahest Product Introduction, Application and Specification
  • 8.1.3 Alkahest Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Baxter
  • 8.2.1 Baxter Human Plasma-Derived Therapeutics Production Sites and Area Served
  • 8.2.2 Baxter Product Introduction, Application and Specification
  • 8.2.3 Baxter Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 CSL Behring
  • 8.3.1 CSL Behring Human Plasma-Derived Therapeutics Production Sites and Area Served
  • 8.3.2 CSL Behring Product Introduction, Application and Specification
  • 8.3.3 CSL Behring Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Entegrion, Inc.
  • 8.4.1 Entegrion, Inc. Human Plasma-Derived Therapeutics Production Sites and Area Served
  • 8.4.2 Entegrion, Inc. Product Introduction, Application and Specification
  • 8.4.3 Entegrion, Inc. Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Gammagard
  • 8.5.1 Gammagard Human Plasma-Derived Therapeutics Production Sites and Area Served
  • 8.5.2 Gammagard Product Introduction, Application and Specification
  • 8.5.3 Gammagard Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Grifols
  • 8.6.1 Grifols Human Plasma-Derived Therapeutics Production Sites and Area Served
  • 8.6.2 Grifols Product Introduction, Application and Specification
  • 8.6.3 Grifols Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Kedrion
  • 8.7.1 Kedrion Human Plasma-Derived Therapeutics Production Sites and Area Served
  • 8.7.2 Kedrion Product Introduction, Application and Specification
  • 8.7.3 Kedrion Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Octapharma
  • 8.8.1 Octapharma Human Plasma-Derived Therapeutics Production Sites and Area Served
  • 8.8.2 Octapharma Product Introduction, Application and Specification
  • 8.8.3 Octapharma Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Prometic Life Sciences
  • 8.9.1 Prometic Life Sciences Human Plasma-Derived Therapeutics Production Sites and Area Served
  • 8.9.2 Prometic Life Sciences Product Introduction, Application and Specification
  • 8.9.3 Prometic Life Sciences Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Sanquin
  • 8.10.1 Sanquin Human Plasma-Derived Therapeutics Production Sites and Area Served
  • 8.10.2 Sanquin Product Introduction, Application and Specification
  • 8.10.3 Sanquin Human Plasma-Derived Therapeutics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Shire

9 Development Trend of Analysis of Human Plasma-Derived Therapeutics Market

• 9.1 Global Human Plasma-Derived Therapeutics Market Trend Analysis
  • 9.1.1 Global Human Plasma-Derived Therapeutics Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Human Plasma-Derived Therapeutics Regional Market Trend
  • 9.2.1 North America Human Plasma-Derived Therapeutics Forecast 2019-2025
  • 9.2.2 Europe Human Plasma-Derived Therapeutics Forecast 2019-2025
  • 9.2.3 China Human Plasma-Derived Therapeutics Forecast 2019-2025
  • 9.2.4 Japan Human Plasma-Derived Therapeutics Forecast 2019-2025
  • 9.2.5 Southeast Asia Human Plasma-Derived Therapeutics Forecast 2019-2025
  • 9.2.6 India Human Plasma-Derived Therapeutics Forecast 2019-2025
• 9.3 Human Plasma-Derived Therapeutics Market Trend (Product Type)
• 9.4 Human Plasma-Derived Therapeutics Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Human Plasma-Derived Therapeutics Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List